Receptors, Interleukin-12
"Receptors, Interleukin-12" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Cell surface receptors for INTERLEUKIN-12. They exist as dimers of beta 1 and beta 2 subunits. Signaling from interleukin-12 receptors occurs through their interaction with JANUS KINASES.
| Descriptor ID |
D053707
|
| MeSH Number(s) |
D12.776.543.750.705.852.420.580
|
| Concept/Terms |
Receptors, Interleukin-12- Receptors, Interleukin-12
- Receptors, Interleukin 12
- Interleukin-12 Receptor
- Interleukin 12 Receptor
- IL-12 Receptor
- IL 12 Receptor
- Receptor, IL-12
- Receptor, Interleukin-12
- Receptor, Interleukin 12
- IL-12 Receptors
- IL 12 Receptors
- Receptors, IL-12
- Interleukin-12 Receptors
- Interleukin 12 Receptors
|
Below are MeSH descriptors whose meaning is more general than "Receptors, Interleukin-12".
Below are MeSH descriptors whose meaning is more specific than "Receptors, Interleukin-12".
This graph shows the total number of publications written about "Receptors, Interleukin-12" by people in this website by year, and whether "Receptors, Interleukin-12" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 0 | 1 | 1 |
| 2011 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Receptors, Interleukin-12" by people in Profiles.
-
Krauthausen M, Ellis SL, Zimmermann J, Sarris M, Wakefield D, Heneka MT, Campbell IL, M?ller M. Opposing roles for CXCR3 signaling in central nervous system versus ocular inflammation mediated by the astrocyte-targeted production of IL-12. Am J Pathol. 2011 Nov; 179(5):2346-59.
-
Sathiyaseelan J, Goenka R, Parent M, Benson RM, Murphy EA, Fernandes DM, Foulkes AS, Baldwin CL. Treatment of Brucella-susceptible mice with IL-12 increases primary and secondary immunity. Cell Immunol. 2006 Sep; 243(1):1-9.
-
Thornley TB, Brehm MA, Markees TG, Shultz LD, Mordes JP, Welsh RM, Rossini AA, Greiner DL. TLR agonists abrogate costimulation blockade-induced prolongation of skin allografts. J Immunol. 2006 Feb 01; 176(3):1561-70.